Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
Covered in this story
Call it yourself
No calls on $SAN.PA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Sanofi →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.